Showing results (71-80 of 79) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 79 results.
AIDS (London, England)|May 23, 2020
Determining standardized causes of death of infants, children, and adolescents living with HIV in AsiaAnnette H Sohn, Pagakrong Lumbiganon, Nia Kurniati, et al.
The Journal of Adolescent Health : Official Publication of the Society for Adolescent Medicine|August 10, 2019
Use and Outcomes of Antiretroviral Monotherapy and Treatment Interruption in Adolescents With Perinatal HIV Infection in AsiaAdam W Bartlett, Pagakrong Lumbiganon, Nia Kurniati, et al.
HIV Medicine|April 14, 2019
Long-term loss to follow-up in the TREAT Asia HIV Observational Database (TAHOD)A Jiamsakul, S Kiertiburanakul, O T Ng, et al.
Journal of Medicinal Chemistry|December 22, 2005
Preparation and biological evaluation of indole, benzimidazole, and thienopyrrole piperazine carboxamides: potent human histamine h(4) antagonistsJennifer D Venable, Hui Cai, Wenying Chai, et al.
Bioorganic & Medicinal Chemistry Letters|June 22, 2010
Pre-clinical characterization of aryloxypyridine amides as histamine H3 receptor antagonists: identification of candidates for clinical developmentMichael A Letavic, Leah Aluisio, John R Atack, et al.
HIV Medicine|December 19, 2019
Early mortality after late initiation of antiretroviral therapy in the TREAT Asia HIV Observational Database (TAHOD) of the International Epidemiologic Databases to Evaluate AIDS (IeDEA) Asia-PacificD Rupasinghe, S Kiertiburanakul, A Kamarulzaman, et al.
Bioorganic & Medicinal Chemistry Letters|November 28, 2006
Novel tetrahydroisoquinolines are histamine H3 antagonists and serotonin reuptake inhibitorsMichael A Letavic, John M Keith, Jill A Jablonowski, et al.
Journal of Virus Eradication|March 17, 2020
Atherosclerotic cardiovascular disease screening and management protocols among adult HIV clinics in AsiaD C Boettiger, M G Law, J Ross, et al.
ACS Medicinal Chemistry Letters|April 21, 2015
Novel benzamide-based histamine h3 receptor antagonists: the identification of two candidates for clinical developmentMichael A Letavic, Leah Aluisio, Richard Apodaca, et al.
Pageof 8